Major Depressive Disorder News and Research

RSS

Major Depressive Disorder (MDD) is a psychiatric condition characterized by depressed mood or anhedonia (significant loss of interest or pleasure). The condition affects more than 15.7 million adults and approximately 3 million adolescents (aged 13 to 17 years) in the USA each year.

Increasing number of cases of wet age-related macular degeneration

Nearly all retina specialists are greatly alarmed by the increasing number of cases of wet age-related macular degeneration (AMD), the leading cause of severe vision loss and blindness in people over the age of 50, and believe the disease will have a serious impact on the public.

11 May 2004

Cymbalta helped patients with depression feel better

Patients treated successfully with 60 mg per day of the investigational antidepressant Cymbalta® (duloxetine hydrochloride), were less likely to have their emotional and physical symptoms of depression return than those who stopped taking medication after beginning to feel better

3 May 2004

Counseling eases the depression of people caring for a loved one with the devastating brain disease

The spouses of Alzheimer's patients often experience extraordinary psychological stress, but a new study by NYU School of Medicine researchers shows that a six-session counseling and long-term support program substantially eases the depression of people caring for a loved one with the devastating brain disease, and that the mental health benefits apparently are long lasting.

1 May 2004

Study shows Levitra enhances patients' self-esteem by improving erections

The first clinical study to evaluate LEVITRA™ (vardenafil HCl) in men with mild Major Depressive Disorder (MDD) and erectile dysfunction (ED) showed LEVITRA produced statistically significant improvements over baseline in all measures of erectile function (EF) and depression/self-esteem. In the study, men taking Levitra were nearly three times more likely to report improved erections than men taking placebo.

24 Mar 2004